This guideline outlines a number of actions recommended to be detect and be prepared to respond to a C.auris case. This includes, similar to CPE guideline, that during the admission process patients that have been admitted to a hospital overseas in the last 12 months are identified and screened (section 4.4). Screening specimens, as a minimum, should include bilateral axilla AND groin (may be combined, for example, two separate swabs placed into one container). In addition, the following sites should be considered: nose and throat, urine (catheterised patients), wound swab, endotracheal secretions, drain fluid, indwelling medical device entry site(s) (section 4.3).
https://www2.health.vic.gov.au/infection-control
